Mandar Ranade - 23 Jun 2023 Form 4 Insider Report for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Jun 2023, 12:35:23 UTC
Prior SEC filing
01 Jul 2022
Next SEC filing
29 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Donald T. Gardner, III, Attorney-in-fact

Key filing fact

Mandar Ranade filed Form 4 for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) on 27 Jun 2023.

Key facts

  • This page summarizes Mandar Ranade's Form 4 filing for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 Jun 2023, 12:35.

Change

  • Previous filing in this sequence was filed on 01 Jul 2022.
  • Current net transaction value: -$27,604.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KEQU transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+5,920
Change %
+110%
Price
$0.000000
Shares after
11,306
Date
23 Jun 2023
Ownership
Direct
Footnotes
F1, F2
KEQU transaction

Common Stock

Tax liability

Transaction value
$27,604
Shares
-1,676
Change %
-15%
Price
$16.47
Shares after
9,630
Date
23 Jun 2023
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KEQU transaction Derivative

Restricted Stock Units FY21

Options Exercise

Transaction value
$0
Shares
-4,915
Change %
-100%
Price
$0.000000*
Shares after
0
Date
23 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,915
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This amount includes 1,005 additional shares that were received upon settlement of the performance-based Restricted Stock Units, originally granted on June 23, 2020, as a result of the performance component of the grant vesting at 125% on June 23, 2023.

Footnote F2

Restricted stock units convert to common stock on a one-for-one basis.

Footnote F3

On June 23, 2020, the reporting person was granted restricted stock units that vest as follows: (a) 40% of the number of restricted stock units subject to the award consist of service-based restricted stock units that vest in three equal annual installments beginning on June 23, 2021, subject to the reporting person's continued employment with the Company, and (b) 60% of the number of restricted stock units subject to the award consist of performance-based restricted stock units that vest only if performance goals are achieved over a three-year period. The actual number of units (if any) received under this award will depend on continued employment and actual performance over the three-year performance period.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .